Mike Costa
Senior Scientist, Discovery Oncology
"I am inspired by my daily interactions here with like-minded scientists driven by a passion for discovery and commitment to translating a deeper understanding of biologic processes into novel disease therapies."
- 9
years at Genentech - 7
publications (2010-12) - 4
awards & honors
I came to Genentech in 2004 to extend my research focus from signal transduction genetics in invertebrate model systems to cancer pathways biology.
I feel that the critical mass of talented scientists and valuable resources at Genentech provides a research environment uniquely suited to uncovering how complex, interacting signaling pathways and their components drive human diseases. Importantly, Genentech also has the expertise and infrastructure to efficiently advance early-stage research discoveries into clinical development of targeted therapies, and through to marketed products that benefit patients.
Featured Publication
Reconstitution of a frizzled8.Wnt3a.LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6.
J Biol Chem 2010 Mar 19; 285(12): 9172-9.
Bourhis E, Tam C, Franke Y, Bazan JF, Ernst J, Hwang J, Costa M, Cochran AG, Hannoush RN.
View Abstract on PubMed
